This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the current use of Kyzatrex (testosterone undecanoate), an oral testosterone treatment from Marinus Pharmaceuticals.

Ticker(s): MRUS

Who's the expert?

Institution: Johns Hopkins University

Bio:

  • Professor of Medicine and Oncology, Director of the Clinical Research Network, and Vice Chair for Faculty Development in the Department of Medicine  
  • Co-chairs the International Registry for Hypogonadal Men and serves as an investigator on several NIH-funded studies evaluating the relationship of sex hormones and cardiovascular risk
  • Has published extensively on topics that include hormonal and other changes with aging and skeletal muscle decline and other effects of chronic disease on the gonadal axis

Interview Goal
to discuss the current standard of care and the use of Kyzatrex (testosterone undecanoate), an oral testosterone treatment from Marinus Pharmaceuticals.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.